ClinicalTrials.gg
CompletedNCT02873715PLANUpdated Jul 26, 2024Results posted

Primary Care Pediatrics Learning Activity and Nutrition With Families

An interventional study of Family-based treatment and Usual Care in Pediatric Obesity, sponsored by State University of New York at Buffalo. Completed at 4 sites in United States. Open to participants aged 6 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-26.

Sponsored by State University of New York at Buffalo · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
1,010
Allocation
Randomized
Ages
6 Years and older
Sex
All
01

Study summary

This study is designed to translate an evidence-based family-based weight loss treatment for childhood obesity (FBT) into primary care settings using co-located interventionists to serve as a model for care delivered within a patient-centered medical home. FBT will be compared to usual care (UC), and the families will be followed for a 2 year period to assess between group differences in the targeted child and parent outcomes, weight changes in non-targeted siblings who are overweight/obese, parent and child changes in delay of gratification, and how these changes relate to weight loss, and the assessment of how provider attitudes predict their intention to use FBT in the future. The results of this study will inform future dissemination and implementation of FBT into primary care settings.

Read the detailed description

Family-based treatment (FBT) is a behavioral weight control intervention that targets children who have overweight/obesity and their parents, and has the capacity to improve the weight status of non-targeted family members such as siblings. FBT has significant positive effects on body weight in children for up to 10-years of follow-up, and a robust relationship is observed between child and parent outcomes. FBT's concurrent care of two generations of obesity in the family is more efficacious and cost-effective than if family members are treated by their separate health care providers. Despite its recognized efficacy, FBT is mainly available in specialty clinics and many children fail to receive this guideline-based level of treatment, as recommended by the U.S. Preventive Services Task Force. Primary care offers an optimal setting for delivery of FBT by capitalizing on the established relationship between primary care providers and families. Using interventionists co-located within the primary care setting overcomes barriers posed by fragmentation of care, and lack of provider time and training. One of the challenges to integrating childhood obesity treatment into primary care is optimizing limited health care resources. In behavioral weight loss programs, some individuals learn diet, physical activity, and behavior change information quickly, while others learn more slowly. Individuals also differ in their ability to implement treatment recommendations due to individual differences, such as problems with delaying gratification. FBT accommodates these individual differences by using a personalized system of instruction, or a mastery model, in which the content and dose of treatment is calibrated to the needs of the family, ensuring that treatment effort is consistent with need. This multi-site, clinical trial aims to evaluate over a two year period the effectiveness of FBT delivered by a trained interventionist co-located within primary care plus usual care delivered by the primary care provider (FBT) compared to usual care (UC). Participants will be a representative sample of 528 families with a 6-12 year-old child and a parent who have both overweight/obesity. Weight changes in approximately 228 siblings who have overweight/obesity and between 2-18 years of age will also be studied. This study will test between group differences in child (Primary Specific Aim 1A) and parent (Secondary Specific Aim 1) weight change, as well as weight change in siblings who have overweight/obesity (Secondary Aim 2), changes in parent and child delay of gratification, and how changes in delay of gratification are related to parent and child weight changes (Secondary Aim 3), participant level predictors of treatment success (Secondary Aim 4), and how provider attitudes toward evidence-based treatment and perceptions of FBT may relate to their intention to use colocated FBT in their practices in the future (Exploratory Aim 1). Establishing that FBT can be effectively implemented within real world settings is crucial to creating a system by which children and their families who suffer from obesity can be treated in a centralized primary care setting.

02

Conditions studied

  • Pediatric Obesity

Browse trials for

Keywords

  • Childhood weight control
03

In context

Pediatric Obesity

1,126 studies on the registry are indexed under Pediatric Obesity; 189 are open to participants now.

This study's enrollment of 1,010 is above the median of 103 across 869 interventional studies indexed under Pediatric Obesity.

Browse Pediatric Obesity studies →

Lead sponsor

State University of New York at Buffalo is the lead sponsor of 294 studies on the registry; 65 are open to participants now.

Of its 19 completed or terminated interventional studies of FDA-regulated products, 15 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

The participating child will be between the ages of 6 and 12 and have a BMI above the 85th percentile for age and sex. The participating child will have at least one parent who has overweight or obesity (BMI>25) and who must agree to attend all parent/child treatment meetings as the participating parent. For families in which one parent has overweight/obesity, this parent will be required to be the participating parent in order for the family to be eligible for the study; if two parents have overweight/obesity, the family will choose one parent to enroll in the study. Similarly, if two children in the family have overweight/obesity, it will be encouraged that the older sibling be the primary participant, as it is more likely the younger sibling will model the older sibling. Though only the child who has overweight/obesity and the participating parent will be required to attend treatment sessions, all family members living in the household, including other adults and siblings, will be encouraged to participate indirectly by supporting changes in the family's lifestyle. Because a secondary aim of the study involves the tracking of treatment effects through the household to non-targeted siblings, heights and weights of at least one sibling with overweight/obesity (BMI>85th percentile for age and sex)in the family will be collected, if applicable. Only siblings ages 2- 18 would qualify. All participants must be able to speak and comprehend English at a first-grade level.

Exclusion criteria

Exclusion Criteria:

The participating parent or child will not have had a concussion in the past three months; will not have any significant developmental delays or intellectual disabilities; will not be receiving treatment for a Diagnostic and Statistical Manual Diploma in Social Medicine (DSM-5) disorder that interferes with treatment delivered as part of the intervention; will not have a physical disability or diagnosis that prevents performance of physical activity at a level equivalent to a brisk walk or that places severe restriction on diet; will not be on a medication regimen that affects weight; will not have a medical condition that alters nutritional status, intestinal absorption, or affects weight; will not have undergone weight loss surgery; and will not be participating in an alternate weight control program. Families in which either the participating child or parent is actively involved in other weight-loss treatment, is using weight-affecting medications, or has an impairing psychiatric or medical condition that would hinder participation in the study will be excluded as identified by the screening assessments. Families that are planning to move or in which the participating parent is pregnant or is planning on becoming pregnant during the 2 year study period will also be excluded.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
1,010 participants (actual)

Study arms

  • Active comparator
    Usual Care (UC)

    Usual Care will consist of the care typically delivered by the family's primary care provider for children with overweight or obesity. The implementations of UC may vary between providers but typically includes and assessment of the child's weight, help remove barriers to weight loss and introductions of goals for better weight management.

    Behavioral: Usual Care

  • Experimental
    Family-based treatment (FBT)

    Family- Based treatment utilizes behavior change techniques to target family-wide changes in diet and physical activity habits with the goal of promoting weight loss and subsequently healthy weight maintenance in all participants. Participants will have visits between 30 to 60 minutes as frequent as weekly and no longer than monthly over the two year study

    Behavioral: Family-based treatment · Behavioral: Usual Care

Interventions

  • BehavioralFamily-based treatment

    Family based treatment as the invention to randomized participants. Family Based treatment utilizes behavior change techniques to target family-wide changes in diet and physical activity habits with the goal of promoting weight loss and subsequently healthy weight maintenance in all participants. Participants will have visits between 30 to 60 minutes as frequent as weekly and no longer than monthly over the two year study

    Also known as: FBT

  • BehavioralUsual Care

    Usual care is a treatment that is normally provided to patients in pediatric offices by a pediatrician, physician assistant, or other primary care staff.

    Also known as: UC

06

What researchers measure

Primary outcomes

  1. Body Composition Measures of Targeted Child. Percent Change Over the Median BMI

    Height and weight will be taken to calculate changes in over weight status for children in FBT versus UC. Change in percent over median BMI from baseline to 24-month. Percent over the age- and sex-specific 50th BMI percentile for kids, percent over the sex-specific 50th BMI percentile for 20-year-olds for parents. Parents are not included in this measurement. This measurement is to describe child body composition and not used for parents. Results are pooled across 10 multiple imputations and reported as mean (standard error)

    Time frame: 0 - 24 months

Secondary outcomes

  1. Body Composition Measures of Participating Parent. BMI (kg/m^2) Change From Baseline to 24 Month

    Height and weight will be taken to calculate changes in over weight status for parents in FBT versus UC. Results are pooled across 10 multiple imputations and reported as mean (standard error)

    Time frame: 0-24 months

  2. Body Composition Measures, Siblings

    Height and weight will be taken for non-targeted siblings to determine if weight loss effects of FBT extend beyond the participating parent and child.

    Time frame: 0-24 months

  3. Delay Discounting

    Delay discounting will be measured using an adjusting amount discounting task with a delayed reward of $100. K-values will be calculated and log-versions will be used due to skewness of k-values. More negative k-values indicate more delayed choices, which is considered better decision making

    Time frame: 0, and 24 months

07

Results

Posted Aug 14, 2023

Participant flow

Each sites local pediatric practices participated in warm hand offs to embeded coaches in the practices to recruit interested families. Families included a targeted child, targeted parent and could include one or multiple siblings but was not required. Recruitment started in November 2017 through August 2019.

Participant flow — Overall Study
MilestoneUsual Care (UC)Family-based Treatment (FBT)
Started504506
6-month follow-up403405
12-month follow-up380386
18-month follow-up380364
24-month follow-up413386
Completed413386
Not completed91120
Withdrew: Lost to follow-up8494
Withdrew: Withdrawal by subject726

Outcome measures

PrimaryBody Composition Measures of Targeted Child. Percent Change Over the Median BMI

Height and weight will be taken to calculate changes in over weight status for children in FBT versus UC. Change in percent over median BMI from baseline to 24-month. Percent over the age- and sex-specific 50th BMI percentile for kids, percent over the sex-specific 50th BMI percentile for 20-year-olds for parents. Parents are not included in this measurement. This measurement is to describe child body composition and not used for parents. Results are pooled across 10 multiple imputations and reported as mean (standard error)

Time frame:
0 - 24 months
Reported as:
Mean · percent change
Body Composition Measures of Targeted Child. Percent Change Over the Median BMI
percent changeUsual Care (UC)Family-based Treatment (FBT)
Body Composition Measures of Targeted Child. Percent Change Over the Median BMI10.2 ± 1.03.4 ± 1.3
Statistical analysis
  • Usual Care (UC) vs Family-based Treatment (FBT) · ANCOVA · p = <0.05 · Mean difference (final values): -6.21 · 95% CI -10.14 to -2.29Results are pooled across 10 multiple imputations and reported as mean (standard error)
SecondaryBody Composition Measures of Participating Parent. BMI (kg/m^2) Change From Baseline to 24 Month

Height and weight will be taken to calculate changes in over weight status for parents in FBT versus UC. Results are pooled across 10 multiple imputations and reported as mean (standard error)

Time frame:
0-24 months
Reported as:
Mean · Change in kg/m^2 (BMI)
Body Composition Measures of Participating Parent. BMI (kg/m^2) Change From Baseline to 24 Month
Change in kg/m^2 (BMI)Usual Care (UC)Family-based Treatment (FBT)
Body Composition Measures of Participating Parent. BMI (kg/m^2) Change From Baseline to 24 Month-0.03 ± 0.22-0.62 ± 0.24
Statistical analysis
  • Usual Care (UC) vs Family-based Treatment (FBT) · ANCOVA · p = 0.001 · Mean difference (final values): -3.97 · 95% CI -5.68 to -2.26Results are pooled across 10 multiple imputations and reported as mean (standard error)
SecondaryBody Composition Measures, Siblings

Height and weight will be taken for non-targeted siblings to determine if weight loss effects of FBT extend beyond the participating parent and child.

Time frame:
0-24 months
Reported as:
Mean · Change in % over median BMI
Body Composition Measures, Siblings
Change in % over median BMIUsual Care (UC)Family-based Treatment (FBT)
Body Composition Measures, Siblings8.3 ± 2.66.6 ± 2.9
SecondaryDelay Discounting

Delay discounting will be measured using an adjusting amount discounting task with a delayed reward of $100. K-values will be calculated and log-versions will be used due to skewness of k-values. More negative k-values indicate more delayed choices, which is considered better decision making

Time frame:
0, and 24 months
Reported as:
Mean · natural log
Delay Discounting
natural logUsual Care (UC)Family-based Treatment (FBT)
Parent baseline delay discounting log k-value-5.98 ± 3.21-6.14 ± 2.54
Parent 24-month Delay discounting log k-value-6.45 ± 2.58-6.75 ± 2.43
Child baseline delay discounting log k-value-4.37 ± 4.02-4.22 ± 3.48
Child 24-month Delay discounting log k-value-4.76 ± 3.23-4.71 ± 2.62
Statistical analysis
  • Usual Care (UC) vs Family-based Treatment (FBT) · ANOVA · p = 0.65 · Mean difference (final values): -0.5384time x group analysis.
  • Usual Care (UC) vs Family-based Treatment (FBT) · ANOVA · p = 0.87 (time x group analysis) · Mean difference (net): -0.3913

Adverse events

Collected over Adverse events and Serious Adverse events were collect over the full two year study, 24 month +/- 3 months.. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Usual Care (UC)0/504 (0%)24/504 (4.8%)314/504 (62.3%)
Family-based Treatment (FBT)0/506 (0%)39/506 (7.7%)345/506 (68.2%)
Most frequent serious events
Showing 10 of 13
Most frequent serious events
EventUsual Care (UC)Family-based Treatment (FBT)
Parent HospitalizationGeneral disorders11/22622/226
Sibling mental healthPsychiatric disorders0/523/54
Sibling hospitalizationGeneral disorders1/522/54
Targeted Child Mental HealthPsychiatric disorders5/2268/226
Parent PregnancyPregnancy, puerperium and perinatal conditions3/2261/226
Parent Mental HealthPsychiatric disorders2/2261/226
Parent InjuryGeneral disorders1/2260/226
Targeted Child Doctor VisitGeneral disorders0/2261/226
Targeted Child HospitalizationsGeneral disorders1/2261/226
Parent Doctor VisitGeneral disorders0/2260/226
Most frequent other events
Showing 10 of 12
Most frequent other events
EventUsual Care (UC)Family-based Treatment (FBT)
Sibling Common Pediatric EventsGeneral disorders17/5220/54
Parent Doctor appointmentsGeneral disorders46/22668/226
Targeted Child Mental HealthPsychiatric disorders52/22648/226
Targeted Child Common Pediatric EventsGeneral disorders50/22642/226
Parent Mental HealthPsychiatric disorders43/22649/226
Targeted Child InjuryGeneral disorders25/22647/226
Sibling Mental HealthGeneral disorders7/5210/54
Sibling Doctor AppointmentsGeneral disorders9/529/54
Parent Common Pediatric EventGeneral disorders37/22628/226
Parent InjuryGeneral disorders34/22635/226

Baseline characteristics

Parents, targeted children are included in the baseline analysis

Age, Continuous
Age, Continuous(years)Usual Care (UC)Family-based Treatment (FBT)Total
Index children9.7 ± 1.99.8 ± 1.99.7 ± 1.9
Parents41.4 ± 7.041.2 ± 7.841.3 ± 7.5
Siblings10.4 ± 3.89.7 ± 3.610.0 ± 3.7
Sex: Female, Male
Sex: Female, Male(Participants)Usual Care (UC)Family-based Treatment (FBT)Total
Targeted Children — Female122120242
Targeted Children — Male104106210
Parents — Female192196388
Parents — Male343064
Siblings — Female303060
Siblings — Male222446
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Usual Care (UC)Family-based Treatment (FBT)Total
Targeted Children — Hispanic or Latino192140
Targeted Children — Not Hispanic or Latino207205412
Targeted Children — Unknown or Not Reported000
Parents — Hispanic or Latino81725
Parents — Not Hispanic or Latino218209427
Parents — Unknown or Not Reported000
Siblings — Hispanic or Latino5611
Siblings — Not Hispanic or Latino474895
Siblings — Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Usual Care (UC)Family-based Treatment (FBT)Total
Targeted Children — American Indian or Alaska Native101
Targeted Children — Asian358
Targeted Children — Native Hawaiian or Other Pacific Islander000
Targeted Children — Black or African American6558123
Targeted Children — White127131258
Targeted Children — More than one race221739
Targeted Children — Unknown or Not Reported81523
Parents — American Indian or Alaska Native000
Parents — Asian336
Parents — Native Hawaiian or Other Pacific Islander000
Parents — Black or African American5558113
Parents — White139148287
Parents — More than one race213
Parents — Unknown or Not Reported271643
Siblings — American Indian or Alaska Native101
Siblings — Asian011
Siblings — Native Hawaiian or Other Pacific Islander000
Siblings — Black or African American131225
Siblings — White212748
Siblings — More than one race5510
Siblings — Unknown or Not Reported12921
Participants
Participants(Participants)Usual Care (UC)Family-based Treatment (FBT)Total
Targeted children226226452
Parents226226452
Siblings5254106
Body mass index (BMI)
Body mass index (BMI)(kg/m^2)Usual Care (UC)Family-based Treatment (FBT)Total
Targeted Children26.9 ± 5.226.7 ± 5.026.8 ± 5.1
Parents37.5 ± 7.936.5 ± 7.637.0 ± 7.8
Siblings27.4 ± 7.924.4 ± 5.625.9 ± 7.0
Child percent over median body mass index
Child percent over median body mass index(percent)Usual Care (UC)Family-based Treatment (FBT)Total
Targeted Children53.8 (15.6 to 177.9)56.1 (15.9 to 187.2)54.7 (15.6 to 187.2)
Sibling51.8 (12.2 to 200.7)37.3 (12.2 to 111.7)41.9 (12.2 to 200.7)
Child BMI percentile
Child BMI percentile(percentile)Usual Care (UC)Family-based Treatment (FBT)Total
Targeted Children98.46 (82.30 to 99.88)98.27 (83.56 to 99.81)98.40 (82.30 to 99.88)
Siblings98.04 (87.12 to 100.0)96.96 (85.22 to 99.95)97.43 (85.22 to 100.00)
08

Study locations

4 sites
  • Washington University in St. Louis
    St Louis, Missouri 63110, United States
  • University at Buffalo
    Buffalo, New York 14214, United States
  • University of Rochester Medical Center
    Rochester, New York 14642, United States
  • Nationwide Childrens Hospital
    Columbus, Ohio 43205, United States
09

References and documents

Publications

  • Kolko RP, Kass AE, Hayes JF, Levine MD, Garbutt JM, Proctor EK, Wilfley DE. Provider Training to Screen and Initiate Evidence-Based Pediatric Obesity Treatment in Routine Practice Settings: A Randomized Pilot Trial. J Pediatr Health Care. 2017 Jan-Feb;31(1):16-28. doi: 10.1016/j.pedhc.2016.01.001. Epub 2016 Feb 9. PubMed 26873293 ↗
  • Maddison R, Marsh S, Foley L, Epstein LH, Olds T, Dewes O, Heke I, Carter K, Jiang Y, Mhurchu CN. Screen-Time Weight-loss Intervention Targeting Children at Home (SWITCH): a randomized controlled trial. Int J Behav Nutr Phys Act. 2014 Sep 10;11:111. doi: 10.1186/s12966-014-0111-2. PubMed 25204320 ↗
  • Epstein LH, Paluch RA, Wrotniak BH, Daniel TO, Kilanowski C, Wilfley D, Finkelstein E. Cost-effectiveness of family-based group treatment for child and parental obesity. Child Obes. 2014 Apr;10(2):114-21. doi: 10.1089/chi.2013.0123. Epub 2014 Mar 21. PubMed 24655212 ↗
  • Quattrin T, Roemmich JN, Paluch R, Yu J, Epstein LH, Ecker MA. Efficacy of family-based weight control program for preschool children in primary care. Pediatrics. 2012 Oct;130(4):660-6. doi: 10.1542/peds.2012-0701. Epub 2012 Sep 17. PubMed 22987879 ↗
  • Theim KR, Sinton MM, Stein RI, Saelens BE, Thekkedam SC, Welch RR, Epstein LH, Wilfley DE. Preadolescents' and parents' dietary coping efficacy during behavioral family-based weight control treatment. J Youth Adolesc. 2012 Jan;41(1):86-97. doi: 10.1007/s10964-011-9728-5. Epub 2011 Nov 12. PubMed 22081241 ↗
  • Button AM, Paluch RA, Schechtman KB, Wilfley DE, Geller N, Quattrin T, Cook SR, Eneli IU, Epstein LH. Parents, but not their children, demonstrate greater delay discounting with resource scarcity. BMC Public Health. 2023 Oct 12;23(1):1983. doi: 10.1186/s12889-023-16832-z. PubMed 37828503 ↗
  • Epstein LH, Rizwan A, Paluch RA, Temple JL. Delay Discounting and the Income-Food Insecurity-Obesity Paradox in Mothers. J Obes. 2023 Sep 19;2023:8898498. doi: 10.1155/2023/8898498. eCollection 2023. PubMed 37766882 ↗
  • Epstein LH, Wilfley DE, Kilanowski C, Quattrin T, Cook SR, Eneli IU, Geller N, Lew D, Wallendorf M, Dore P, Paluch RA, Schechtman KB. Family-Based Behavioral Treatment for Childhood Obesity Implemented in Pediatric Primary Care: A Randomized Clinical Trial. JAMA. 2023 Jun 13;329(22):1947-1956. doi: 10.1001/jama.2023.8061. PubMed 37314275 ↗

Study documents

  • Protocol, analysis plan and consent form · Nov 17, 2020

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02873715
Responsible party
Leonard Epstein (Principal Investigator, State University of New York at Buffalo) — Principal investigator
First posted
Aug 19, 2016
Start date
Nov 20, 2017
Primary completion
Aug 31, 2021
Completion
Aug 31, 2021
Results posted
Aug 14, 2023
Last update
Jul 26, 2024

Study contacts

Leonard H Epstein, PhD
principal investigator · State University of New York at Buffalo
Denise Wilfley, PhD
principal investigator · Washington University in Saint Louis
Ken Schechtman, PhD
principal investigator · Washington University in Saint Louis

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion